Cargando…

Weight-Based Bisphosphonate Administration for Multiple Myeloma Patients and the Risks of Skeletal Complications

High-dose bisphosphonate for multiple myeloma patients might elevate risks of skeletal complications earlier than general expectations. This study aims to find incidences of atypical femoral fracture (AFF) and medication-related osteonecrosis of the jaw (MRONJ), elucidate their risk factors, and sug...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bahk, Ji Hoon, Jo, Woo-Lam, Kwon, Soon-Yong, Park, Hyung Chul, Lim, Young Wook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961848/ https://www.ncbi.nlm.nih.gov/pubmed/36836169 http://dx.doi.org/10.3390/jcm12041637

Ejemplares similares

Evaluation of Frequency of Administration of Intravenous Bisphosphonate and Recurrent Skeletal-Related Events in Patients With Multiple Myeloma
por: Zhou, Jifang, et al.
Publicado: (2021)

Evolving therapeutic role of bisphosphonates in multiple myeloma
por: Ural, A U, et al.
Publicado: (2005)

Multiple Myeloma and the Role of Bisphosphonates in Its Management
por: Tanveer, Nida, et al.
Publicado: (2023)

Is the construct stability of the acetabular cup affected by the acetabular screw configuration in bone defect models?
por: Nam, Ho-Jin, et al.
Publicado: (2023)

Lateral pillar is the key in supporting pre-collapse osteonecrosis of the femoral head: a finite element model analysis of propensity-score matched cohorts
por: Bahk, Ji Hoon, et al.
Publicado: (2021)

Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients
por: Walter, Christian, et al.
Publicado: (2010)

Osteonecrosis of the Jaw After Bisphosphonates Treatment in Patients with Multiple Myeloma
por: Krstevska, Svetlana, et al.
Publicado: (2015)

P948: REAL-WORLD EVIDENCE OF BISPHOSPHONATES FOR MULTIPLE MYELOMA
por: Muñoz, Maria Nieves Lopez, et al.
Publicado: (2023)

Non-thermal atmospheric pressure plasma treatment increases hydrophilicity and promotes cell growth on titanium alloys in vitro
por: Jo, Woo-Lam, et al.
Publicado: (2023)

Multiple Myeloma and Bisphosphonate-Related Osteonecrosis of the Mandible Associated with Dental Implants
por: Junquera, Luis, et al.
Publicado: (2011)

Conservative Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw in Multiple Myeloma Patients
por: Melea, Pelagia I., et al.
Publicado: (2014)

Paradoxical Stress Fracture in a Patient With Multiple Myeloma and Bisphosphonate Use
por: Chiu, Edwin, et al.
Publicado: (2020)

Cutaneous Abscess as a Complication of Bisphosphonate-Related Osteonecrosis of the Jaw
por: Yang, Min-Young, et al.
Publicado: (2018)

Bisphosphonate-related osteonecrosis of the jaw in a multiple myeloma patient: A case report with characteristic radiographic features
por: Lee, Byung-Do, et al.
Publicado: (2015)

Impact on Bisphosphonate Persistence and Compliance: Daily Postprandial Administration
por: Park, Chan Ho, et al.
Publicado: (2019)

Difference in Bone Mineral Density Change at the Lateral Femoral Cortices according to Administration of Different Bisphosphonate Agents
por: Kim, Sungjun, et al.
Publicado: (2016)

Initiation and interruption in intravenous bisphosphonate therapy among patients with multiple myeloma in the United States
por: McGrath, Leah J., et al.
Publicado: (2018)

Paget's Disease: Skeletal Manifestations and Effect of Bisphosphonates
por: Kang, Ho, et al.
Publicado: (2017)

Does the Time of Postoperative Bisphosphonate Administration Affect the Bone Union in Osteoporotic Intertrochanteric Fracture of Femur?
por: Cho, Yoon Je, et al.
Publicado: (2015)

Bilateral Atypical Femoral Fractures in a Patient with Multiple Myeloma Treated with Intravenous Bisphosphonate Therapy
por: Tonogai, Ichiro, et al.
Publicado: (2014)

Dental implant in a multiple myeloma patient undergoing bisphosphonate therapy: A case report
por: Bayani, Mojtaba, et al.
Publicado: (2019)

Multiple myeloma: imaging evaluation of skeletal disease
por: Sexton, Carlton, et al.
Publicado: (2013)

Administration of bisphosphonate for hypercalcemia associated with oral cancer
por: Onizawa, Kojiro, et al.
Publicado: (2006)

Eliminating the need for fasting with oral administration of bisphosphonates
por: Pazianas, Michael, et al.
Publicado: (2013)

Bioinformatics analyses of differentially expressed genes associated with bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma
por: Sun, Jingnan, et al.
Publicado: (2015)

Altered Long Noncoding RNA Expression Profile in Multiple Myeloma Patients with Bisphosphonate-Induced Osteonecrosis of the Jaw
por: Allegra, Alessandro, et al.
Publicado: (2020)

Prospective Observational Study of Bisphosphonate-Related Osteonecrosis of the Jaw in Multiple Myeloma: Microbiota Profiling and Cytokine Expression
por: Badros, Ashraf Z., et al.
Publicado: (2021)

A systematic review and meta-analysis of interventional studies of bisphosphonates and denosumab in multiple myeloma and future perspectives
por: Chatziravdeli, Vasiliki, et al.
Publicado: (2022)

Evolution of bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma and Waldenstrom's macroglobulinemia: a retrospective multicentric study
por: Andriani, A, et al.
Publicado: (2012)

Prevention Of Skeletal Related Events In Multiple Myeloma: Focus On The RANK-L Pathway In The Treatment Of Multiple Myeloma
por: Parrondo, Ricardo D, et al.
Publicado: (2019)

Regeneration of Cochlear Synapses by Systemic Administration of a Bisphosphonate
por: Seist, Richard, et al.
Publicado: (2020)

Immunohistochemical Femoral Nerve Study Following Bisphosphonates Administration
por: Karakousis, Vasileios Alexandros, et al.
Publicado: (2020)

Bisphosphonates-related osteonecrosis of the jaw in Korea: a preliminary report
por: Lee, Jeong Keun, et al.
Publicado: (2013)

Atypical Complete Femoral Fractures Associated with Bisphosphonate Use or Not Associated with Bisphosphonate Use: Is There a Difference?
por: Kim, Sang-Min, et al.
Publicado: (2016)

Bisphosphonates in oncology: evidence for the prevention of skeletal events in patients with bone metastases
por: Polascik, Thomas J
Publicado: (2009)

Best Practice for the Administration of Daratumumab in Multiple Myeloma: Australian Myeloma Nurse Expert Opinion
por: King, Tracy, et al.
Publicado: (2018)

Comparative Study of Peripheral Rim Fixation Using Jumbo Cup in Revisional Hip Arthroplasty
por: Jo, Woo-Lam, et al.
Publicado: (2017)

Insufficiency Fracture of Ipsilateral Femur Neck in Patient Treated with Long Term Bisphosphonate Treatment - A Case Report -
por: Kim, Do-Hoon, et al.
Publicado: (2012)

Osteonecrosis of the Jaws (ONJ) after Bisphosphonate Treatment in Patients with Multiple Myeloma: Decreasing ONJ Incidence after Adoption of Preventive Measures
por: Catania, Gioacchino, et al.
Publicado: (2016)

The Importance of Alliance between Hematologists and Dentists: A Retrospective Study on the Development of Bisphosphonates Osteonecrosis of the Jaws (Bronj) in Multiple Myeloma Patients
por: Bacci, Christian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_36dr7cf7us4klm3j9gkgr4nivd